FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage

Clin Gastroenterol Hepatol. 2020 Feb;18(2):517-519. doi: 10.1016/j.cgh.2018.11.011. Epub 2018 Dec 8.

Abstract

Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Elasticity Imaging Techniques*
  • Fibrosis
  • Humans
  • Liver / pathology
  • Liver Cirrhosis / diagnostic imaging
  • Liver Cirrhosis / pathology
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / pathology